
Dark Genome Biotech HERVolution Therapeutics Announces $11.7M Series A to Advance Treatments for Cancer & Diseases of Aging
Published on December 19, 2024
a $11.7 million Series A financing to advance its lead assets toward clinical evaluation. The funding round was led by Serum Institute of
